Steve Albers is Senior Vice President, Market Access and Public Affairs for Novo Nordisk Inc. since November 2020. Steve leads the US Market Access team in setting strategies and providing national leadership in communicating the value of all Novo Nordisk products to …

Novo Nordisk also offers a free of charge home generated medical sharps containment and disposal system to CA and MN residents using our product portfolio. These services are also made available by Novo Nordisk to patients in other states.

Novo Nordisk’s product portfolio includes several injectable medications (in both vial and pen device) that require the use of needles, as well as pen needles. More information about Novo Nordisk and our products available in the United States can be found by visiting https://www.novonordisk-us.com.

Learn about the Novo Nordisk Industry Practice PharmD Fellowship, a competitive postdoctoral opportunity for recent PharmD graduates. View information about the program here.

Learn all about Novo Nordisk in the U.S. and how we're helping to defeat diabetes, rare bleeding disorders, growth hormone-related disorders, and obesity.

PLAINSBORO, NJ, December 23, 2022 – Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Wegovy ® (semaglutide) injection 2.4 mg, making it the first-and-only prescription anti …

Do you want to be part of a large, inspirational, global HR Business Partnering community in Novo Nordisk - a community focused on enabling the Line of Business in executing their business strategies - a community on a journey to being proactive strategic partners …

Novo Nordisk is the only company with FDA-approved, prescription-only semaglutide medicines: Wegovy ®, Ozempic ®, and Rybelsus ®. No other FDA-approved generic or alternative semaglutide medicines exist.

Related jobs Work with us See all jobs NOVO NORDISK USA 800 Scudders Mill Road Plainsboro, NJ 08536 Tel: 1-609-987-5800

At Novo Nordisk Site Hillerød, we are around 4,000 employees developing, producing, and filling injection pens to help patients around the world living with serious chronic diseases, such as diabetes and obesity.